Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KALV by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−187,848−100.0%Sold outHolders
Q1 2026187,848$3.78M<0.1%+76,041+68.0%AddedHolders
Q4 2025111,807$1.81M<0.1%+19,439+21.0%AddedHolders
Q3 202592,368$1.13M<0.1%−41,198−30.8%ReducedHolders
Q2 2025133,566$1.51M<0.1%+50,670+61.1%AddedHolders
Q1 202582,896$956.6K<0.1%+891+1.1%AddedHolders
Q4 202482,005$694.6K<0.1%+15,582+23.5%AddedHolders
Q3 202466,423$769.2K<0.1%+12,397+22.9%AddedHolders
Q2 202454,026$636.4K<0.1%+3,119+6.1%AddedHolders
Q1 202450,907$603.8K<0.1%−63−0.1%ReducedHolders
Q4 202350,970$624.4K<0.1%−6,596−11.5%ReducedHolders
Q3 202357,566$554.4K<0.1%−13,299−18.8%ReducedHolders
Q2 202370,865$637.8K<0.1%−300.0%ReducedHolders
Q1 202370,895$557.2K<0.1%−1,240,107−94.6%ReducedHolders
Q4 20221,311,002$8.86M<0.1%+152,617+13.2%AddedHolders
Q3 20221,158,385$16.8M<0.1%+25,943+2.3%AddedHolders
Q2 20221,132,442$11.1M<0.1%+307,092+37.2%AddedHolders
Q1 2022825,350$12.2M<0.1%+38,130+4.8%AddedHolders
Q4 2021787,220$10.4M<0.1%−173,741−18.1%ReducedHolders
Q3 2021960,961$16.8M<0.1%−127,829−11.7%ReducedHolders
Q2 20211,088,790$26.1M<0.1%−259,180−19.2%ReducedHolders
Q1 20211,347,970$34.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.